儿科移植中的药物坚持:如何在混乱的水上建造一座桥梁
Fabienne Dobbels1, Jo Wray2,3,4
1Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Pediatric transplantation
|November 27, 2023
概括
坚持免疫抑制药物治疗是儿科移植接受者面临的主要挑战. 本综述概述了有效的,可持续的干预措施,以改善这些年轻患者的药物坚持.
科学领域:
- 儿科脏病学 儿科脏病学
- 移植免疫学 移植免疫学
- 坚持研究 坚持研究
背景情况:
- 药物坚持对于儿科移植接受者的长期移植存活至关重要.
- 在这个人群中,不坚持是一个重大而持久的挑战.
- 以前的研究,包括Fine博士45多年前的基础工作,一直试图理解和解决不坚持.
研究的目的:
- 提供对儿童脏移植增强坚持性干预措施的综合性审查.
- 专注于有效,临床上可嵌入和可持续的策略.
- 讨论患者的移植前干预和再移植决策与非粘附诱导的移植损失.
主要方法:
- 关于加强坚持的干预措施的综合文献综述.
- 分析识别需要支持的患者的策略.
- 讨论干预和再移植的时间和决策.
主要成果:
- 确定了各种适用于儿科移植接受者的增强坚持的干预措施.
- 强调早期和持续支持的重要性.
- 提供了关于管理因不粘附引起的移植损失和再移植的指导.
结论:
- 有效和可持续的干预措施至关重要,以克服儿科脏移植的不坚持.
- 需要采用多方面的方法,包括移植前的干预措施和仔细考虑再移植.
- 改善粘附性可以显著影响移植的存活率和患者的结果.
关键词:
没有遵守的不遵守.相关概念视频
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Factors Affecting Renal Clearance: Renal Impairment
99
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
99
Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Renal Drug Excretion: Tubular Secretion
192
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
192
Renal Drug Excretion: Tubular Reabsorption
189
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
189


